Germany · Delayed Price · Currency is EUR Proteome Sciences Statistics
Total Valuation
FRA:PI2 has a market cap or net worth of EUR 5.52 million. The enterprise value is 22.73 million.
| Market Cap | 5.52M |
| Enterprise Value | 22.73M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 295.18M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -3.71% |
| Owned by Insiders (%) | 13.93% |
| Owned by Institutions (%) | 48.71% |
| Float | 184.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.05 |
| PB Ratio | -0.55 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.85 |
| EV / Sales | 4.41 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -13.15 |
Financial Position
The company has a current ratio of 0.11
| Current Ratio | 0.11 |
| Quick Ratio | 0.08 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -10.39 |
| Interest Coverage | -2.51 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -15.93% |
| Return on Invested Capital (ROIC) | -18.70% |
| Return on Capital Employed (ROCE) | 31.14% |
| Revenue Per Employee | 146,700 |
| Profits Per Employee | -108,008 |
| Employee Count | 36 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 5.92 |
Taxes
In the past 12 months, FRA:PI2 has paid 187,822 in taxes.
| Income Tax | 187,822 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.38% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -57.38% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 47.08 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:PI2 had revenue of EUR 5.28 million and -3.89 million in losses. Loss per share was -0.01.
| Revenue | 5.28M |
| Gross Profit | 920,446 |
| Operating Income | -2.65M |
| Pretax Income | -3.70M |
| Net Income | -3.89M |
| EBITDA | -2.49M |
| EBIT | -2.65M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 306,815 in cash and 17.96 million in debt, giving a net cash position of -17.65 million.
| Cash & Cash Equivalents | 306,815 |
| Total Debt | 17.96M |
| Net Cash | -17.65M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -10.01M |
| Book Value Per Share | -0.03 |
| Working Capital | -16.25M |
Cash Flow
In the last 12 months, operating cash flow was -1.41 million and capital expenditures -318,481, giving a free cash flow of -1.73 million.
| Operating Cash Flow | -1.41M |
| Capital Expenditures | -318,481 |
| Free Cash Flow | -1.73M |
| FCF Per Share | n/a |
Margins
Gross margin is 17.43%, with operating and profit margins of -50.12% and -73.62%.
| Gross Margin | 17.43% |
| Operating Margin | -50.12% |
| Pretax Margin | -70.07% |
| Profit Margin | -73.62% |
| EBITDA Margin | -47.16% |
| EBIT Margin | -50.12% |
| FCF Margin | n/a |
Dividends & Yields
FRA:PI2 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -70.39% |
| FCF Yield | -31.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:PI2 has an Altman Z-Score of -15.17 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.17 |
| Piotroski F-Score | 3 |